Incidents of viral outbreaks have increased at an alarming rate over the past decades. The
most recent human coronavirus known as COVID-19 (SARS-CoV-2) has already spread …

This review article describes the use of immune cells as potential candidates to deliver anti-
cancer drugs deep within the tumor microenvironment. First, the rationale of using drug …

The therapeutic potential of liposomes to deliver drugs into inflamed tissue is well
documented. Liposomes are believed to largely transport drugs into inflamed joints by …

Although the first nanomedicine was clinically approved more than two decades ago,
nanoparticles'(NP) in vivo behavior is complex and the immune system's role in their …

Interactions of various ligands and receptors have been extensively investigated because
they regulate a series of signal transduction leading to various functional cellular outcomes …

Optimized therapeutic bio-compounds supported by bio-acceptable nanosystems (ie,
precise nanomedicine) have ability to promote health via maintaining body structure, organ …

Biomaterial carriers offer modular features to control the delivery and presentation of
vaccines and immunotherapies. This tunability is a distinct capability of biomaterials …

Sepsis is characterized by a dysregulated immune response and is very difficult to treat. In
the cecal ligation and puncture (CLP) mouse model, we show that nanomedicines can …

Ligands, mostly binding to proteins to form complexes and catalyze chemical reactions, can
serve as drug and probe molecules, as well as sensing elements. DNA nanotechnology can …

Highlights•Cancer nanomedicine traditionally aims to target chemotherapeutic drugs to
tumors.•Chemotherapy targeting does not overcome the treatment-response-relapse vicious …